Contrast enhanced ultrasound in the assessment of urogenital pathology


Submitted: January 23, 2015
Accepted: January 23, 2015
Published: December 30, 2014
Abstract Views: 2180
PDF: 1254
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Contrast enhanced ultrasound (CEUS) is an innovative technique that employs microbubble contrast agents to demonstrate parenchymal perfusion. Although initial clinical application was focused on the liver pathology, a wide variety of clinical conditions can be assessed now with CEUS. CEUS is a well-tolerated technique and is acquiring an increasing role in the assessment of renal pathology because contrast agents are not excreted by the kidney and do not affect the renal function. CEUS demonstrated an accuracy similar to contrast enhanced multi-detector computed tomography (CEMDCT) in detecting focal lesions, with the advantage of the real-time assessment of microvascular perfusion by using time-intensity curves. The aim of this paper is to review the main indications of CEUS in the assessment of renal and urogenital pathology. Imaging examples are presented and described. Advantages and limitations of CEUS with reference to conventional US and CE-MDCT are discussed.

Barozzi, L., Capannelli, D., & Imbriani, M. (2014). Contrast enhanced ultrasound in the assessment of urogenital pathology. Archivio Italiano Di Urologia E Andrologia, 86(4), 319–324. https://doi.org/10.4081/aiua.2014.4.319

Downloads

Download data is not yet available.

Citations


Similar Articles

You may also start an advanced similarity search for this article.